We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Par Pacific Holdings
PARR
$3.92B
| $6.7M | 0.1% |
376,354
+66,600
| +22% | +$1.1M |
|
277
ePlus
PLUS
$2.33B
| $6.68M | 0.1% |
150,838
+58,066
| +63% | +$2.41M |
|
|
CLDR
278
DELISTED
Cloudera, Inc.
CLDR
| $6.65M | 0.1% |
607,825
+108,491
| +22% | +$1.39M |
|
279
Adtran
ADTN
$771M
| $6.64M | 0.1% |
484,484
+48,800
| +11% | +$674K |
|
280
Devon Energy
DVN
$50B
| $6.57M | 0.09% |
208,190
+22,290
| +12% | +$623K |
|
281
Cimpress
CMPR
$2.4B
| $6.53M | 0.09% |
+81,505
| New | +$7.45M |
|
282
Pacira BioSciences
PCRX
$1.05B
| $6.49M | 0.09% |
170,439
+71,150
| +72% | +$2.78M |
|
|
AEL
283
DELISTED
American Equity Investment Life Holding Company
AEL
| $6.47M | 0.09% |
239,427
+61,170
| +34% | +$1.85M |
|
284
Brunswick
BC
$5.23B
| $6.43M | 0.09% |
127,798
-85,866
| -40% | -$4.33M |
|
|
DMC
285
Del Monte Corp
DMC
$1.36B
| $6.37M | 0.09% |
235,577
+67,076
| +40% | +$1.97M |
|
286
Masco
MAS
$16.3B
| $6.37M | 0.09% |
161,990
-63,330
| -28% | -$2.26M |
|
|
RST
287
DELISTED
ROSETTA STONE INC
RST
| $6.36M | 0.09% |
291,274
-12,864
| -4% | -$224K |
|
288
Primoris Services
PRIM
$4.61B
| $6.35M | 0.09% |
306,997
+90,070
| +42% | +$1.89M |
|
|
FSCT
289
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $6.34M | 0.09% |
151,292
+45,230
| +43% | +$1.62M |
|
290
Equity Residential
EQR
$25.3B
| $6.34M | 0.09% |
84,155
-188,470
| -69% | -$13.6M |
|
291
Genesco
GCO
$411M
| $6.32M | 0.09% |
138,686
-43,280
| -24% | -$1.98M |
|
292
Rush Enterprises Class A
RUSHA
$6.01B
| $6.27M | 0.09% |
337,239
+5,242
| +2% | +$92.9K |
|
293
Forward Air
FWRD
$474M
| $6.24M | 0.09% |
96,377
-22,511
| -19% | -$1.38M |
|
294
Eli Lilly
LLY
$1.07T
| $6.11M | 0.09% |
47,107
-68,962
| -59% | -$8.39M |
|
295
Theravance Biopharma
TBPH
$875M
| $6.09M | 0.09% |
268,813
+94,070
| +54% | +$2.39M |
|
296
CSX Corp
CSX
$95.8B
| $6.09M | 0.09% |
244,080
-60,780
| -20% | -$1.41M |
|
|
FLOW
297
DELISTED
SPX FLOW, Inc.
FLOW
| $6.07M | 0.09% |
190,357
+40,420
| +27% | +$1.33M |
|
298
Rayonier
RYN
$6.52B
| $6.06M | 0.09% |
211,866
-31,171
| -13% | -$832K |
|
299
Toro Company
TTC
$9.03B
| $6.05M | 0.09% |
87,944
-33,480
| -28% | -$2.12M |
|
300
Usana Health Sciences
USNA
$415M
| $5.96M | 0.09% |
71,054
+25,610
| +56% | +$2.67M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.